[Clinical evaluation of the Undofen aerosol preparation manufactured by Polfa].
D000336:Aerosols; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy*; D004003:Dichlorophen / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006582:Hexachlorophene / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D014476:Undecylenic Acids / Q000008:administration & dosage / Q000627:therapeutic use*
D000336:Aerosols; D004338:Drug Combinations; D014476:Undecylenic Acids; C014239:undofen; D006582:Hexachlorophene; D004003:Dichlorophen
Ocena kliniczna preparatu Undofen aerozol "Polfa"